BR112013034055A2 - alcaftadina para uso no tratamento de urticária - Google Patents

alcaftadina para uso no tratamento de urticária

Info

Publication number
BR112013034055A2
BR112013034055A2 BR112013034055A BR112013034055A BR112013034055A2 BR 112013034055 A2 BR112013034055 A2 BR 112013034055A2 BR 112013034055 A BR112013034055 A BR 112013034055A BR 112013034055 A BR112013034055 A BR 112013034055A BR 112013034055 A2 BR112013034055 A2 BR 112013034055A2
Authority
BR
Brazil
Prior art keywords
alcaftadine
urticaria
treatment
Prior art date
Application number
BR112013034055A
Other languages
English (en)
Inventor
N Lalwani Dinusha
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BR112013034055A2 publication Critical patent/BR112013034055A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
BR112013034055A 2011-06-29 2012-06-29 alcaftadina para uso no tratamento de urticária BR112013034055A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161502563P 2011-06-29 2011-06-29
PCT/US2012/045141 WO2013003825A1 (en) 2011-06-29 2012-06-29 Alcaftadine for use in the treatment of urticaria

Publications (1)

Publication Number Publication Date
BR112013034055A2 true BR112013034055A2 (pt) 2017-02-07

Family

ID=46881142

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013034055A BR112013034055A2 (pt) 2011-06-29 2012-06-29 alcaftadina para uso no tratamento de urticária

Country Status (10)

Country Link
US (1) US20130005708A1 (pt)
EP (1) EP2726080A1 (pt)
JP (1) JP2014518278A (pt)
KR (1) KR20140074881A (pt)
CN (1) CN103764150A (pt)
AU (1) AU2012275113A1 (pt)
BR (1) BR112013034055A2 (pt)
CA (1) CA2840731A1 (pt)
RU (1) RU2014102493A (pt)
WO (1) WO2013003825A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104955453B (zh) * 2012-12-19 2018-09-18 原生质生物科学股份有限公司 Lfa-1抑制剂制剂
US20140235618A1 (en) * 2013-02-21 2014-08-21 Allergan, Inc. Methods for treatment of atopic dermatitis and inflammatory skin disorders
US20140243300A1 (en) * 2013-02-28 2014-08-28 Precision Dermatology, Inc. Controlling the Bioavailability of Active Ingredients in Topical Formulations
AU2014242317B2 (en) * 2013-03-14 2018-12-20 Allergan, Inc. Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith
US11666239B2 (en) 2017-03-14 2023-06-06 University Of Connecticut Biodegradable pressure sensor
WO2019173402A1 (en) * 2018-03-05 2019-09-12 University Of Connecticut Core-shell microneedle platform for transdermal and pulsatile drug/vaccine delivery and method of manufacturing the same
US20210115155A1 (en) * 2018-03-26 2021-04-22 Novartis Ag Methods of treating chronic spontaneous urticaria using ligelizumab
US11826495B2 (en) 2019-03-01 2023-11-28 University Of Connecticut Biodegradable piezoelectric ultrasonic transducer system
US11678989B2 (en) 2019-03-01 2023-06-20 University Of Connecticut Biodegradable piezoelectric nanofiber scaffold for bone or tissue regeneration
US11745001B2 (en) 2020-03-10 2023-09-05 University Of Connecticut Therapeutic bandage
AU2021437358A1 (en) * 2021-04-01 2023-09-14 Alkem Laboratories Limited Nasal compositions comprising alcaftadine

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4316893A (en) 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
SE9101022D0 (sv) 1991-01-09 1991-04-08 Paal Svedman Medicinsk suganordning
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5814599A (en) 1995-08-04 1998-09-29 Massachusetts Insitiute Of Technology Transdermal delivery of encapsulated drugs
KR0134152B1 (ko) 1994-05-23 1998-04-14 이형도 의약품 투여용 피부흠집 형성장치
JP2551742B2 (ja) 1994-05-23 1996-11-06 三星電機株式会社 医薬品投与用皮膚傷形成装置
AU5740496A (en) 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
US6002961A (en) 1995-07-25 1999-12-14 Massachusetts Institute Of Technology Transdermal protein delivery using low-frequency sonophoresis
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6148232A (en) 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US8399410B2 (en) 2007-08-06 2013-03-19 Allergan, Inc. Methods and devices for desmopressin drug delivery
CN102283849A (zh) * 2011-06-29 2011-12-21 北京阜康仁生物制药科技有限公司 一种含有阿卡他定的药物组合物

Also Published As

Publication number Publication date
KR20140074881A (ko) 2014-06-18
CA2840731A1 (en) 2013-01-03
AU2012275113A1 (en) 2014-01-30
WO2013003825A1 (en) 2013-01-03
EP2726080A1 (en) 2014-05-07
RU2014102493A (ru) 2015-08-10
US20130005708A1 (en) 2013-01-03
JP2014518278A (ja) 2014-07-28
CN103764150A (zh) 2014-04-30

Similar Documents

Publication Publication Date Title
BR112013034055A2 (pt) alcaftadina para uso no tratamento de urticária
CO6930363A2 (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
CO6870033A2 (es) Compuestos terapéuticos y métodos de uso relacionados
CO6801796A2 (es) Composiciones de tratamiento de pozo de liberación retardada para uso en fluídos de tratamiento de pozo
CR20140119A (es) Composición y apósito para tratamiento de heridas
BR112013024401A2 (pt) métodos e composições para o tratamento do transtorno do déficit de atenção
BRPI1013698A2 (pt) métodos para tratamento com o uso de terapia de combinação
BR112015001712A2 (pt) uso de s-pindolol para o tratamento da caquexia e sarcopenia
BR112014013843A2 (pt) uso de dispositivos para o tratamento de doenças neurológicas
CO6920293A2 (es) Compuestos antibaterianos y método para su uso
FI20115647A0 (fi) Järjestely lattian hiontaan
BR112015002706A2 (pt) niclosamida e seus derivados para uso no tratamento de tumores sólidos
BR112013022523A2 (pt) uso de glicopirrolato para o tratamento de taquicardia
BR112015006512A2 (pt) composição para tratar tecidos biológicos danificados
BR112013014540A2 (pt) artigo absorvente e método para preparar o mesmo
FI20116306A (fi) Teroitin
BR112014022694A2 (pt) novos métodos e composições para o tratamento de doença
BR112015008798A2 (pt) método para o tratamento de plantas e uso
BR112014014504A2 (pt) uso de partícula
BR112014005406A2 (pt) composição de vacina e respectivo uso
BR112014002102A2 (pt) curativo para ferimentos e métodos para fazer o curativo para ferimentos
ZA201306613B (en) Combinations comprising macitentan for the treatment of glioblastoma multiforme
BR112014029487A2 (pt) método para o tratamento cosmético
BR112014002830A2 (pt) fotossensibilizador para uso terapêutico
BR112013028890A2 (pt) composições e métodos para o tratamento de câncer

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]